Shopping Cart
- Remove All
Your shopping cart is currently empty
NF449 is a potent antagonist of the P2X1 receptor, displaying IC50 values of 0.28 nM, 0.69 nM, and 120 nM for rP2X1, rP2X1+5, and P2X2+3, respectively. It acts selectively against Gsα G proteins (G Protein). NF449 inhibits the binding rate of GTP[γS] to Gsα-s, suppresses the stimulation of adenylate cyclase activity, and blocks the coupling of β-adrenergic receptors with Gs.


| Description | NF449 is a potent antagonist of the P2X1 receptor, displaying IC50 values of 0.28 nM, 0.69 nM, and 120 nM for rP2X1, rP2X1+5, and P2X2+3, respectively. It acts selectively against Gsα G proteins (G Protein). NF449 inhibits the binding rate of GTP[γS] to Gsα-s, suppresses the stimulation of adenylate cyclase activity, and blocks the coupling of β-adrenergic receptors with Gs. |
| In vitro | NF449 hinders the binding rate of GTP[γS] to rGsα-s while having minimal effect on rGiα-1 binding (IC 50 = 140 nM). It suppresses the stimulation of adenylate cyclase activity in S49 cyc- membranes (lacking endogenous Gsα) through exogenously added Gsα-s and obstructs the coupling of β-adrenergic receptors with Gs (EC 50 = 7.9 μM). |
| In vivo | At a dosage of 10 mg/kg, NF449 inhibits platelet aggregation triggered by 5 g/mL collagen in WT mice without affecting aggregation induced by 5 μM ADP. At a higher dose (50 mg/kg), NF449 inhibits ex vivo platelet aggregation in response to both 10 g/mL collagen and 5 μM ADP, indicating non-selective inhibition of P2Y1 and/or P2Y12 receptors. |
| Molecular Weight | 1329.24 |
| Formula | C41H32N6O29S8 |
| Cas No. | 389142-38-5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.